Oppenheimer Asset Management Inc. Increases Holdings in Doximity, Inc. (NASDAQ:DOCS)

Oppenheimer Asset Management Inc. boosted its position in Doximity, Inc. (NASDAQ:DOCS) by 48.2% during the second quarter, Holdings Channel.com reports. The institutional investor owned 22,705 shares of the company’s stock after purchasing an additional 7,385 shares during the period. Oppenheimer Asset Management Inc.’s holdings in Doximity were worth $635,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently bought and sold shares of the business. Norges Bank purchased a new stake in shares of Doximity in the 4th quarter valued at $35,995,000. Blair William & Co. IL grew its position in Doximity by 31.7% during the 1st quarter. Blair William & Co. IL now owns 90,600 shares of the company’s stock worth $2,438,000 after purchasing an additional 21,787 shares during the period. Edmond DE Rothschild Holding S.A. raised its stake in shares of Doximity by 15.1% during the 4th quarter. Edmond DE Rothschild Holding S.A. now owns 2,302,240 shares of the company’s stock valued at $64,555,000 after buying an additional 301,290 shares during the last quarter. Pinebridge Investments L.P. acquired a new position in shares of Doximity in the 4th quarter valued at about $2,845,000. Finally, Acadian Asset Management LLC boosted its stake in shares of Doximity by 128.7% in the first quarter. Acadian Asset Management LLC now owns 96,442 shares of the company’s stock worth $2,590,000 after buying an additional 54,281 shares during the last quarter. Institutional investors and hedge funds own 87.19% of the company’s stock.

Analyst Ratings Changes

Several research analysts recently weighed in on the company. Bank of America lifted their price target on Doximity from $29.00 to $32.00 and gave the company a “neutral” rating in a research report on Friday, August 9th. Morgan Stanley boosted their target price on shares of Doximity from $25.00 to $26.00 and gave the company an “underweight” rating in a research note on Friday, August 9th. Robert W. Baird raised their price target on shares of Doximity from $41.00 to $45.00 and gave the company an “outperform” rating in a research report on Tuesday. Wells Fargo & Company downgraded shares of Doximity from an “equal weight” rating to an “underweight” rating and decreased their price objective for the stock from $27.00 to $19.00 in a research report on Thursday, July 18th. Finally, Barclays raised their target price on Doximity from $31.00 to $35.00 and gave the company an “equal weight” rating in a research report on Friday, August 9th. Two analysts have rated the stock with a sell rating, eight have given a hold rating, four have given a buy rating and one has assigned a strong buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average price target of $32.42.

Doximity Stock Performance

NASDAQ DOCS opened at $40.89 on Friday. Doximity, Inc. has a one year low of $19.71 and a one year high of $41.05. The business has a fifty day moving average price of $33.20 and a 200 day moving average price of $29.00. The company has a market cap of $7.58 billion, a P/E ratio of 56.79, a P/E/G ratio of 5.15 and a beta of 1.27.

Doximity (NASDAQ:DOCS) last posted its quarterly earnings results on Thursday, August 8th. The company reported $0.22 earnings per share for the quarter, topping the consensus estimate of $0.16 by $0.06. Doximity had a net margin of 32.53% and a return on equity of 19.26%. The firm had revenue of $126.68 million for the quarter, compared to the consensus estimate of $119.88 million. As a group, sell-side analysts predict that Doximity, Inc. will post 0.8 EPS for the current fiscal year.

Insider Transactions at Doximity

In related news, Director Watkin Phoebe L. Yang sold 1,011 shares of the stock in a transaction that occurred on Monday, August 5th. The stock was sold at an average price of $25.54, for a total value of $25,820.94. Following the completion of the sale, the director now owns 11,258 shares of the company’s stock, valued at $287,529.32. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In related news, Director Watkin Phoebe L. Yang sold 1,940 shares of the firm’s stock in a transaction dated Monday, July 29th. The shares were sold at an average price of $28.22, for a total transaction of $54,746.80. Following the completion of the sale, the director now directly owns 12,269 shares in the company, valued at $346,231.18. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Also, Director Watkin Phoebe L. Yang sold 1,011 shares of Doximity stock in a transaction dated Monday, August 5th. The stock was sold at an average price of $25.54, for a total transaction of $25,820.94. Following the transaction, the director now directly owns 11,258 shares in the company, valued at $287,529.32. The disclosure for this sale can be found here. Insiders have sold a total of 37,951 shares of company stock worth $1,271,018 in the last ninety days. Insiders own 39.40% of the company’s stock.

Doximity Company Profile

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.